AI-powered insights from the Veradigm Network reveal real-world GLP-1 outcomes hidden in EHR data
Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today an advancement in the use of artificial intelligence (AI) to scale the generation of real-world evidence (RWE) for GLP-1 receptor agonists (GLP-1…
Article Source
https://www.stocktitan.net/news/MDRX/veradigm-advances-glp-1-real-world-evidence-generation-with-ai-4cdcfg3omxol.html
:max_bytes(150000):strip_icc()/GettyImages-2154451134-a960071f1c934441a5f06cd65b42effe.jpg?resize=1500,960&ssl=1 "Amazon Follows Google, Meta, and Microsoft With Plans To Boost Spending on AI")